SELLAS Life Sciences Group, Inc. SLS Operating lease liabilities
Operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s operating lease liabilities?
- SELLAS Life Sciences Group, Inc. (SLS) reported operating lease liabilities of -$159K in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s operating lease liabilities changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s operating lease liabilities decreased by 0.0% year-over-year, from -$159K to -$159K.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s operating lease liabilities?
- Over 3 years (2022 to 2025), SELLAS Life Sciences Group, Inc.'s operating lease liabilities has grown at a 10.5% compound annual growth rate (CAGR), from -$471K to -$635K.